Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Journal of Virology|March 18, 2011
Vaccination alters the balance between protective immunity, exhaustion, escape, and death in chronic infectionsPhilip L F Johnson, Beth F Kochin, Megan S McAfee, et al.Virology|November 1, 2003
Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulationRobbert G van der Most, Kaja Murali-Krishna, J Gibson Lanier, et al.Proceedings of the National Academy of Sciences of the United States of America|April 2, 2015
TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopesDiego Chowell, Sri Krishna, Pablo D Becker, et al.Virology|May 2, 2017
A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particlesLydia R Meador, Sarah A Kessans, Jacquelyn Kilbourne, et al.Nature|August 13, 2004
Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5Yongliang Zhang, Joseph N Blattman, Norman J Kennedy, et al.Immunity|October 24, 2007
Molecular signature of CD8+ T cell exhaustion during chronic viral infectionE John Wherry, Sang-Jun Ha, Susan M Kaech, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 10, 2015
Enhanced T-cell immunity to osteosarcoma through antibody blockade of PD-1/PD-L1 interactionsDanielle M Lussier, Lauren O'Neill, Lizbeth M Nieves, et al.Cancers|January 21, 2022
Systemic Delivery of mLIGHT-Armed Myxoma Virus Is Therapeutic for Later-Stage Syngeneic Murine Lung Metastatic OsteosarcomaJohn D Christie, Nicole Appel, Liqiang Zhang, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 23, 2003
Preferential escape of subdominant CD8+ T cells during negative selection results in an altered antiviral T cell hierarchyMark K Slifka, Joseph N Blattman, David J D Sourdive, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 17, 2012
Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivoIngunn M Stromnes, Carla Fowler, Chanel C Casamina, et al.Pageof 5